Placentex is an injectable solution containing polydeoxyribonucleotide (PDRN) 5.625 mg in 3 ml - a purified DNA fraction with regenerative properties. Manufactured in Italy by Mastelli, the original developer of PDRN therapy. Classified as a cicatrizant (wound healing) and anti-dystrophic agent.
Route of administration: intramuscular or subcutaneous, as prescribed by a physician.
Polydeoxyribonucleotide is a purified DNA extract that supports tissue repair. Its mechanism is studied in regenerative medicine: PDRN activates adenosine A2A receptors and provides nucleotide building blocks for cell renewal - supporting healing, tissue trophism and repair processes.
PDRN has decades of clinical use in Italy in wound care, trophic ulcers and tissue regeneration protocols; it is also widely known in aesthetic regenerative medicine.
PDRN in Placentex helps:
Intramuscular or subcutaneous administration by a qualified healthcare professional. Dose and course length are set by the physician; typical protocols run several weeks with periodic courses.
Generally well tolerated. Local reactions at the injection site or transient hypersensitivity may occur. Contraindicated in hypersensitivity to the components. Use during pregnancy and breastfeeding only under medical supervision.
A purified DNA fraction that supports tissue repair - it activates regenerative pathways (adenosine A2A receptors) and provides nucleotides for cell renewal. Used in wound healing and regenerative medicine.
Same molecule class (PDRN, salmon-derived DNA) - Placentex is the original medical product by Mastelli, Italy, used in medicine; aesthetic products are based on the same research.
Both are per the label; the route, dose and schedule are set by the physician.
Typically several weeks per course, with periodic repeats - per physician.
Yes - prescription-only medicine.
Ask a question or inquire about delivery to your country


